Trial Details
TERMINATEDBasic Information
| Clinical ID | c3317 |
|---|---|
| Identifier | NCT02240108 |
| Trial Title | One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Rifaximin EIR|DRUG: Placebo |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Huntsville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-10-28 |
|---|---|
| Primary Completion Date | 2017-10-06 |
| Completion Date | 2017-10-06 |